ImmuPharma plc (IMM.L)
GBp 1.11
(0.68%)
GBp 1.11
(0.68%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.06 Million GBP | 1.12% |
| 2022 | 3.02 Million GBP | -42.61% |
| 2021 | 5.27 Million GBP | -7.66% |
| 2020 | 5.71 Million GBP | -10.12% |
| 2019 | 6.35 Million GBP | -22.08% |
| 2018 | 8.16 Million GBP | 10.52% |
| 2017 | 7.38 Million GBP | 9.34% |
| 2016 | 6.75 Million GBP | 45.57% |
| 2015 | 4.63 Million GBP | 28.53% |
| 2014 | 3.6 Million GBP | -14.63% |
| 2013 | 4.22 Million GBP | 1.27% |
| 2012 | 4.17 Million GBP | 8.36% |
| 2011 | 3.85 Million GBP | -8.52% |
| 2010 | 4.21 Million GBP | -64.17% |
| 2009 | 11.75 Million GBP | 124.74% |
| 2008 | 5.23 Million GBP | 47.27% |
| 2007 | 3.55 Million GBP | 0.0% |
| 2005 | 1.55 Million GBP | 5275.86% |
| 2004 | 29 Thousand GBP | 93.33% |
| 2003 | 15 Thousand GBP | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 382.11 Thousand GBP | 0.0% |
| 2024 Q1 | 382.11 Thousand GBP | -54.9% |
| 2023 Q3 | 1.02 Million GBP | -21.67% |
| 2023 Q1 | 684.18 Thousand GBP | -46.51% |
| 2023 FY | 3.14 Million GBP | 3.84% |
| 2023 Q4 | 847.31 Thousand GBP | -17.4% |
| 2023 Q2 | 1.3 Million GBP | 91.41% |
| 2022 Q1 | 834.75 Thousand GBP | -63.75% |
| 2022 FY | 3.02 Million GBP | -42.61% |
| 2022 Q2 | 1.63 Million GBP | 95.54% |
| 2022 Q3 | 1.39 Million GBP | -14.67% |
| 2022 Q4 | 1.27 Million GBP | -8.17% |
| 2021 Q1 | 1.93 Million GBP | -27.44% |
| 2021 Q2 | 3.01 Million GBP | 55.79% |
| 2021 Q3 | 2.53 Million GBP | -16.12% |
| 2021 Q4 | 2.3 Million GBP | -9.01% |
| 2021 FY | 5.27 Million GBP | -7.66% |
| 2020 Q3 | 2.13 Million GBP | -25.87% |
| 2020 Q2 | 2.87 Million GBP | 96.99% |
| 2020 FY | 5.71 Million GBP | -10.12% |
| 2020 Q1 | 1.45 Million GBP | -53.55% |
| 2020 Q4 | 2.66 Million GBP | 25.22% |
| 2019 Q1 | 2.04 Million GBP | 6.89% |
| 2019 FY | 6.35 Million GBP | -22.08% |
| 2019 Q3 | 1.36 Million GBP | -57.84% |
| 2019 Q2 | 3.24 Million GBP | 59.07% |
| 2019 Q4 | 3.14 Million GBP | 129.45% |
| 2018 Q2 | 2.11 Million GBP | 0.0% |
| 2018 Q4 | 1.91 Million GBP | 0.0% |
| 2018 Q3 | 1.91 Million GBP | -9.5% |
| 2018 Q1 | 2.11 Million GBP | 9.08% |
| 2018 FY | 8.16 Million GBP | 10.52% |
| 2017 FY | 7.38 Million GBP | 9.34% |
| 2017 Q4 | 1.93 Million GBP | 0.0% |
| 2017 Q3 | 1.93 Million GBP | 18.27% |
| 2017 Q2 | 1.63 Million GBP | -0.0% |
| 2017 Q1 | 1.63 Million GBP | 1.14% |
| 2016 Q3 | 1.61 Million GBP | -0.18% |
| 2016 FY | 6.75 Million GBP | 45.57% |
| 2016 Q2 | 1.62 Million GBP | 0.0% |
| 2016 Q1 | 1.62 Million GBP | 5.13% |
| 2016 Q4 | 1.61 Million GBP | 0.0% |
| 2015 FY | 4.63 Million GBP | 28.53% |
| 2015 Q2 | 775.41 Thousand GBP | -0.0% |
| 2015 Q3 | 1.54 Million GBP | 98.89% |
| 2015 Q4 | 1.54 Million GBP | 0.0% |
| 2015 Q1 | 775.41 Thousand GBP | -12.14% |
| 2014 Q4 | 882.56 Thousand GBP | 0.0% |
| 2014 Q2 | 909.2 Thousand GBP | 0.0% |
| 2014 Q1 | 909.2 Thousand GBP | -31.15% |
| 2014 FY | 3.6 Million GBP | -14.63% |
| 2014 Q3 | 882.56 Thousand GBP | -2.93% |
| 2013 Q1 | 926.46 Thousand GBP | -18.83% |
| 2013 Q3 | 1.32 Million GBP | 42.55% |
| 2013 Q4 | 1.32 Million GBP | 0.0% |
| 2013 FY | 4.22 Million GBP | 1.27% |
| 2013 Q2 | 926.46 Thousand GBP | -0.0% |
| 2012 FY | 4.17 Million GBP | 8.36% |
| 2012 Q4 | 1.14 Million GBP | 0.0% |
| 2012 Q3 | 1.14 Million GBP | 0.0% |
| 2011 FY | 3.85 Million GBP | -8.52% |
| 2010 FY | 4.21 Million GBP | -64.17% |
| 2009 FY | 11.75 Million GBP | 124.74% |
| 2008 FY | 5.23 Million GBP | 47.27% |
| 2007 FY | 3.55 Million GBP | 0.0% |
| 2006 Q2 | - GBP | 0.0% |
| 2005 FY | 1.55 Million GBP | 5275.86% |
| 2004 FY | 29 Thousand GBP | 93.33% |
| 2003 FY | 15 Thousand GBP | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|